# Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women

> **NCT03365466** · — · UNKNOWN · sponsor: **Shanghai First Maternity and Infant Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Recurrent Implantation Failure

## Interventions

- **DRUG:** Low dose aspirin
- **DRUG:** Low molecular weight heparin
- **DRUG:** Low dose aspirin plus low molecular weight heparin
- **DRUG:** no treatment

## Key facts

- **NCT ID:** NCT03365466
- **Lead sponsor:** Shanghai First Maternity and Infant Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12
- **Primary completion:** 2018-12
- **Final completion:** 2019-02
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03365466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03365466, "Anticoagulation Therapies Effect on the Endometrial Blood Flow and Pregnancy Outcomes in Unexplained Recurrent Implantation Failure Women". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03365466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*